An intriguing question is why anti-TNF is able to induce a psoriatic phenotype in wild-type mice and enhance type I IFN production by pDCs from blood of healthy donors, but only 2–5% of anti-TNF-treated patients develop paradoxical psoriasis. Here, TNF is linked to psoriasis.